TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T25315	C-X-C chemokine receptor type 3	B1TF6Q	N-[2-(Dimethylamino)ethyl]-N-[1-[3-(4-hydroxyphenyl)-4-oxoquinazolin-2-yl]ethyl]decanamide	Investigative	44402658	C30H42N4O3	506.7	CCCCCCCCCC(=O)N(CCN(C)C)C(C)C1=NC2=CC=CC=C2C(=O)N1C3=CC=C(C=C3)O	IC50 ~ 100000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	B49JSR	2-(2-Acetyl-6-phenylbenzimidazol-1-yl)-1-(4-bromophenyl)ethanone	Investigative	44454617	C23H17BrN2O2	433.3	CC(=O)C1=NC2=C(N1CC(=O)C3=CC=C(C=C3)Br)C=C(C=C2)C4=CC=CC=C4	IC50 ~ 50000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	B68NBJ	4-(3-Chloro-5-(methylcarbamoyl)pyridin-2-yl)-1-(1-(4-chlorobenzyl)piperidin-4-yl)piperazine-2-carboxylic acid	Investigative	53324328	C24H29Cl2N5O3	506.4	CNC(=O)C1=CC(=C(N=C1)N2CCN(C(C2)C(=O)O)C3CCN(CC3)CC4=CC=C(C=C4)Cl)Cl	IC50 ~ 50000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	B7D4YQ	1-[(4-Chloro-2-fluorophenyl)methyl]-N-(3,3-diphenylpropyl)piperidin-4-amine	Investigative	44592138	C27H30ClFN2	437	C1CN(CCC1NCCC(C2=CC=CC=C2)C3=CC=CC=C3)CC4=C(C=C(C=C4)Cl)F	Ki ~ 100000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	B9BM0T	2-(2-Acetyl-5-phenylbenzimidazol-1-yl)-1-(4-bromophenyl)ethanone	Investigative	44454616	C23H17BrN2O2	433.3	CC(=O)C1=NC2=C(N1CC(=O)C3=CC=C(C=C3)Br)C=CC(=C2)C4=CC=CC=C4	IC50 ~ 50000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	BDR4M1	N-[1-Methyl-3-[2-(4-nitrophenyl)-2-oxoethyl]benzimidazol-2-ylidene]acetamide	Investigative	44454589	C18H16N4O4	352.3	CC(=O)N=C1N(C2=CC=CC=C2N1CC(=O)C3=CC=C(C=C3)[N+](=O)[O-])C	IC50 = 50000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	BG37DA	N-[2-(Dimethylamino)ethyl]-N-[1-[4-oxo-3-[4-(trifluoromethyl)phenyl]quinazolin-2-yl]ethyl]decanamide	Investigative	44402504	C31H41F3N4O2	558.7	CCCCCCCCCC(=O)N(CCN(C)C)C(C)C1=NC2=CC=CC=C2C(=O)N1C3=CC=C(C=C3)C(F)(F)F	IC50 ~ 100000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	BIXM95	2-(2-Acetyl-1H-benzimidazol-1-yl)-1-phenylethanone	Investigative	384454	C17H14N2O2	278.3	CC(=O)C1=NC2=CC=CC=C2N1CC(=O)C3=CC=CC=C3	IC50 ~ 100000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	BJ4W0L	N,4-Dimethyl-N-(2-(thiophene-3-carbonyl)phenyl)benzenesulfonamide	Investigative	46225413	C19H17NO3S2	371.5	CC1=CC=C(C=C1)S(=O)(=O)N(C)C2=CC=CC=C2C(=O)C3=CSC=C3	IC50 ~ 60000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	BMHY14	4-[2-(2-Acetylbenzimidazol-1-yl)acetyl]benzonitrile	Investigative	44454645	C18H13N3O2	303.3	CC(=O)C1=NC2=CC=CC=C2N1CC(=O)C3=CC=C(C=C3)C#N	IC50 ~ 100000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	BQY1C7	1-(5-Chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)piperazin-1-yl)pyridin-3-yl)-3-(3,4-dichlorophenyl)urea	Investigative	45484740	C28H30Cl4N6O	608.4	C1CN(CCC1N2CCN(CC2)C3=C(C=C(C=N3)NC(=O)NC4=CC(=C(C=C4)Cl)Cl)Cl)CC5=CC=C(C=C5)Cl	Ki ~ 50000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	BUIR78	2-(2-Acetyl-5-methoxybenzimidazol-1-yl)-1-(4-bromophenyl)ethanone	Investigative	44454618	C18H15BrN2O3	387.2	CC(=O)C1=NC2=C(N1CC(=O)C3=CC=C(C=C3)Br)C=CC(=C2)OC	IC50 ~ 50000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	BWZ3I1	[(4-Methylphenyl)sulfonyl](2-{[(4-methylphenyl)sulfonyl]prop-2-enylamino}pheny l)prop-2-enylamine	Investigative	3453336	C26H28N2O4S2	496.6	CC1=CC=C(C=C1)S(=O)(=O)N(CC=C)C2=CC=CC=C2N(CC=C)S(=O)(=O)C3=CC=C(C=C3)C	IC50 ~ 60000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	BXB65G	2-(2-Acetyl-6-methoxybenzimidazol-1-yl)-1-(4-bromophenyl)ethanone	Investigative	44454619	C18H15BrN2O3	387.2	CC(=O)C1=NC2=C(N1CC(=O)C3=CC=C(C=C3)Br)C=C(C=C2)OC	IC50 ~ 50000 nM	Poor binder
T25315	C-X-C chemokine receptor type 3	BZA14G	n,n'-1,2-Phenylenebis(n,4-dimethylbenzenesulfonamide)	Investigative	265219	C22H24N2O4S2	444.6	CC1=CC=C(C=C1)S(=O)(=O)N(C)C2=CC=CC=C2N(C)S(=O)(=O)C3=CC=C(C=C3)C	IC50 ~ 60000 nM	Poor binder